These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 1557063

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron.
    Knoll J.
    J Neural Transm Suppl; 1987; 25():45-66. PubMed ID: 2828537
    [Abstract] [Full Text] [Related]

  • 9. (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties.
    Magyar K, Szende B.
    Neurotoxicology; 2004 Jan; 25(1-2):233-42. PubMed ID: 14697898
    [Abstract] [Full Text] [Related]

  • 10. R-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition.
    Klegeris A, McGeer PL.
    Exp Neurol; 2000 Dec; 166(2):458-64. PubMed ID: 11085911
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Apomorphine offers new insight into dopaminergic neuron vulnerability in mesencephalic cultures.
    Vaglini F, Pardini C, Viaggi C, Caramelli A, Corsini GU.
    Neuropharmacology; 2008 Oct; 55(5):737-42. PubMed ID: 18634808
    [Abstract] [Full Text] [Related]

  • 19. Modification of levodopa responses by deprenyl (selegiline): an electrophysiological and behavioral study in the rat relevant to Parkinson's disease.
    Mercuri NB, Scarponi M, Federici M, Bonci A, Siniscalchi A, Bernardi G.
    Ann Neurol; 1998 May; 43(5):613-7. PubMed ID: 9585355
    [Abstract] [Full Text] [Related]

  • 20. Fine ultrastructure and biochemistry of PC12 cells: a comparative approach to understand neurotoxicity.
    Fornai F, Lenzi P, Lazzeri G, Ferrucci M, Fulceri F, Giorgi FS, Falleni A, Ruggieri S, Paparelli A.
    Brain Res; 2007 Jan 19; 1129(1):174-90. PubMed ID: 17157274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.